CSI Market
Sign In | Register

Manhattan Scientifics Inc (MHTX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MHTX quarterly Cash Flow →
Tracking cash flow results across Manhattan Scientifics Inc to Dec 31 2019 helps illustrate how Dec 31 2023's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-1.17
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.01
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.02
Debt Discount And Original Issue Discount Accretion-
Treasury Stock Cancelled And Returned To Authorized-
Deconsolidation Gain Or Loss Amount-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Stock Issued During Period Value Issued For Services-
Stock Options Issued Vested For Services-
Loss Gain On Fair Value Adjustment Of Investments-
Common Stock Issued For Services-
Gain Loss Related To Litigation Settlement-
Income taxes0.00
Loss on Sale of Investments0.48
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable0.49
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.19
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Assets Held For Sale-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Long-term Investments0.10
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.02
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.00
Payment On Related Party Note Payable-
Stock Repurchased During Period Value-
Payments For Payments On Notes Payable Other-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.02
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.19
Total Cash Flow-0.11
4 historic quarters locked

Sign in to unlock the full Manhattan Scientifics Inc cash flow history.

Sign In Create Free Account

About Manhattan Scientifics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 2, 2024
  • Source: mhtx_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477932-24-001766

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document